The compound remains in research status, lacking the clinical trial data required for regulatory approval
A double-blind, randomized, comparative study of the use of a combination of uridine triphosphate trisodium, cytidine monophosphate disodium, and hydroxocobalamin, versus isolated treatment with hydroxocobalamin, in patients presenting with compressive neuralgias
In September 2023, the FDA added BPC-157 to its Category 2 list of bulk drug substances under its Interim Policy on Compounding, meaning 503A compounding pharmacies and 503B outsourcing facilities are barred from using it in compounded preparations
The copper peptide used in the study is a glycyl-L-histidyl-L-lysine tripeptide -1 serum booster (Brand name skin perfection), which is readily available as 0.51% serum
His team is best known for identifying MOTS -c, which has been called an exercise mimetic: it activates cellular pathways that are usually turned on during exercise